Kite Pharma Overview
- Year Founded
-
2009
- Status
-
Acquired/Merged
- Employees
-
4,025
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$11.2B
Kite Pharma General Information
Description
Operator of a clinical-stage biopharmaceutical company intended to bring the promise of cell therapy to cancer patients. The company focuses on the development and commercialization of novel cancer immunotherapy products designed to harness the power of a patient's own immune system to eradicate cancer cells.
Contact Information
Website
www.kitepharma.com(Operating Subsidiary)
Corporate Office
- 2400 Broadway
- Santa Monica, CA 90404
- United States
Corporate Office
- 2400 Broadway
- Santa Monica, CA 90404
- United States
Kite Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 03-Oct-2017 | $11.2B | Completed | Generating Revenue | ||
| 5. Secondary Transaction - Open Market | 01-Apr-2015 | Completed | Generating Revenue | |||
| 4. IPO | 20-Jun-2014 | Completed | Generating Revenue | |||
| 3. Mezzanine | 28-Apr-2014 | Completed | Generating Revenue/Not Profitable | |||
| 2. Early Stage VC (Series A) | 15-May-2013 | $35M | $35M | Completed | Generating Revenue/Not Profitable | |
| 1. University Spin-Out | 01-Jan-2009 | Completed | Startup |
Kite Pharma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
Kite Pharma Comparisons
Industry
Financing
Details
Kite Pharma Competitors (50)
One of Kite Pharma’s 50 competitors is NexImmune, a Formerly VC-backed company based in Gaithersburg, MD.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| NexImmune | Formerly VC-backed | Gaithersburg, MD | ||||
| Gadeta | Formerly VC-backed | Utrecht, Netherlands | ||||
| Carisma Therapeutics | Formerly VC-backed | Philadelphia, PA | ||||
| Genocea Biosciences | Formerly VC-backed | Cambridge, MA | ||||
| Adimab | Venture Capital-Backed | Lebanon, NH |
Kite Pharma Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Kite Pharma Patents
Kite Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250043998-A1 | Apparatuses, systems, and methods for storing and transporting a temperature sensitive material | Pending | 04-Aug-2023 | ||
| US-20240366670-A1 | Allogenic therapeutic cells with reduced risk of immune rejection | Pending | 21-Apr-2023 | ||
| US-20240309428-A1 | Impact of tumor microenvironment on efficacy of immunotherapy | Pending | 17-Mar-2023 | ||
| US-20240310265-A1 | Systems and methods for detecting suspended particles in fluids | Pending | 17-Mar-2023 | ||
| US-20240343820-A1 | Antigen binding molecules and methods of use | Pending | 09-Mar-2023 | C07K16/2887 |
Kite Pharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Kite Pharma Former Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alta Partners | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| BB Biotech | Asset Manager | Minority | ||
| Bellco Capital | PE/Buyout | Minority | ||
| Bloom8 | Venture Capital | Minority |
Kite Pharma Investments & Acquisitions (14)
Kite Pharma’s most recent deal was a PIPE with Arcellx for . The deal was made on 15-Dec-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Arcellx | 15-Dec-2023 | PIPE | Drug Discovery | ||
| Tmunity | 22-Feb-2023 | Merger/Acquisition | Biotechnology | ||
| AlloVir | 26-Jul-2022 | PIPE | Biotechnology | ||
| Shoreline Biosciences | 02-Nov-2021 | Early Stage VC | Drug Discovery | ||
| Appia Bio | 11-May-2021 | Early Stage VC | Biotechnology |
Kite Pharma ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Kite Pharma FAQs
-
When was Kite Pharma founded?
Kite Pharma was founded in 2009.
-
Where is Kite Pharma headquartered?
Kite Pharma is headquartered in Santa Monica, CA.
-
What is the size of Kite Pharma?
Kite Pharma has 4,025 total employees.
-
What industry is Kite Pharma in?
Kite Pharma’s primary industry is Biotechnology.
-
Is Kite Pharma a private or public company?
Kite Pharma is a Private company.
-
What is the current valuation of Kite Pharma?
The current valuation of Kite Pharma is .
-
What is Kite Pharma’s current revenue?
The current revenue for Kite Pharma is .
-
How much funding has Kite Pharma raised over time?
Kite Pharma has raised $212M.
-
Who are Kite Pharma’s investors?
Alta Partners, , BB Biotech, Bellco Capital, and Bloom8 are 5 of 13 investors who have invested in Kite Pharma.
-
Who are Kite Pharma’s competitors?
NexImmune, Gadeta, Carisma Therapeutics, Genocea Biosciences, and Adimab are some of the 50 competitors of Kite Pharma.
-
When was Kite Pharma acquired?
Kite Pharma was acquired on 03-Oct-2017.
-
Who acquired Kite Pharma?
Kite Pharma was acquired by Gilead Sciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
